LEADER 02588nam  2200565Ia 450 
001 9910456141903321
005 20200520144314.0
010   $a1-282-41254-X
010   $a9786612412547
010   $a0-309-13837-X
035   $a(CKB)2420000000001444
035   $a(EBL)3378540
035   $a(SSID)ssj0000438155
035   $a(PQKBManifestationID)12160749
035   $a(PQKBTitleCode)TC0000438155
035   $a(PQKBWorkID)10452362
035   $a(PQKB)11642112
035   $a(MiAaPQ)EBC3378540
035   $a(Au-PeEL)EBL3378540
035   $a(CaPaEBR)ebr10347043
035   $a(CaONFJC)MIL241254
035   $a(OCoLC)923280906
035   $a(EXLCZ)992420000000001444
100   $a20090921d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aInitial national priorities for comparative effectiveness research$b[electronic resource] /$fCommittee on Comparative Effectiveness Research Prioritization, Board on Health Care Services, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2009
215   $a1 online resource (252 p.)
300   $aDescription based upon print version of record.
311   $a0-309-13836-1 
320   $aIncludes bibliographical references.
327   $a""Reviewers""; ""Foreword""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 What Is Comparative Effectiveness Research?""; ""3 Obtaining Input to Identify National Priorities for Comparative Effectiveness Research""; ""4 The Criteria and Process for Setting Priorities""; ""5 Priorities for Study""; ""6 Essential Priorities for a Robust CER Enterprise""; ""Appendix A: Public Meeting Agendaa???March 20, 2009""; ""Appendix B: Stakeholder Questionnaire""; ""Appendix C: Data Tables: Burden of Disease and Variation of Care""
327   $a""Appendix D: Cardiovascular and Peripheral Vascular Cover Sheet""""Appendix E: Definitions of Medical Terminology in CER Priority List""; ""Appendix F: Committee Biographies""
606   $aMedicine$xResearch$zUnited States
606   $aMedical policy$zUnited States
608   $aElectronic books.
615  0$aMedicine$xResearch
615  0$aMedical policy
676   $a610.72073
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456141903321
996   $aInitial national priorities for comparative effectiveness research$92283422
997   $aUNINA

LEADER 01236nam a2200337 i 4500
001 991001197109707536
005 20020507112739.0
008 941010s1993    uk            ||| | eng  
020   $a0521373204
035   $ab10187157-39ule_inst
035   $aLE00643769$9ExL
040   $aDip.to Fisica$bita
084   $a53.1.4
084   $a53.3.11
084   $a530.143
084   $aQC174.45
100 1 $aKorepin, V.E.$0463619
245 10$aQuantum inverse scattering method and correlation functions /$cV.E. Korepin, N.M. Bogoliubov, A.G. Izergin
260   $aCambridge ; New York :$bCambridge University Press,$c1993
300   $axix, 555 p. ;$c26 cm.
490 0 $aCambridge monographs on mathematical physics
500   $aIncludes bibliographical references (p. 520-553) and index.
650  4$aCorrelation
700 1 $aIzergin, A.G.
700 1 $aBogoliubov, N.N.
907   $a.b10187157$b17-02-17$c27-06-02
912   $a991001197109707536
945   $aLE006 53.3.11 KOR$g1$i2006000084253$lle006$o-$pE0.00$q-$rl$s-  $t0$u7$v0$w7$x0$y.i10230427$z27-06-02
996   $aQuantum inverse scattering method and correlation functions$9190312
997   $aUNISALENTO
998   $ale006$b01-01-94$cm$da  $e-$feng$guk $h0$i1